Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /home/clients/e018409a36d8d382bd5c9d12746db954/sites/oncodesign-joomla.propulse.dev/plugins/system/helix3/core/classes/menu.php on line 89


Access a full range of services for studying the metabolism and pharmacokinetics of your drug candidates—from their selection through to their approval by the regulatory authorities

We assess the metabolic and pharmacokinetic characteristics of chemical and biological substances, and can provide you with a range of customised services to characterize their ADME-T (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties.

A wide range of offerings from early stage to post-marketing phase

A wide range of offerings throughout the drug develpment process

Early in vitro ADME

ADME DMPK drug discovery step

Early in vitro ADME studies are a crucial step in a molecule’s discovery phase. The accurate results from these studies can be used to identify the best drug candidates. The earlier the data is produced, the more effective the identification of the critical stages will be and the greater your chances of shortening development times.

Access a full range of services for your early in vitro ADME assessment as well as for the metabolic studies of drugs to select your best molecules.

Early in vivo ADME

Oncodesign has developed expertise in identifying the early pharmacokinetic profile (plasma and/or target organ) on rodent species to accelerate the optimization of the chosen molecule and the selection of drug candidates.

Animal pharmacokinetics and metabolism

ADME DMPK preclinical

Whatever the administration routes used with radio-labelled or non-radio-labelled compounds, Oncodesign can provide tailored solutions for your animal pharmacokinetics and metabolism studies:

  • Mass balance studies (including CO2 expired)
  • Quantitative whole-body autoradiography (QWBA)
  • Tissular distribution (transplacental transmission, BBB, transcutaneous)
  •  Biliary excretion
  • Pharmacokinetics of plasma and urine (single or repeat dose using the Empis Pump method, sample-taking methods using traditional methods, such as Dry Blood Spot).

Human pharmacokinetics and metabolism

Our human pharmacokinetics department can provide advice and meet your needs for all aspects of clinical pharmacokinetics.

ADME DMPK clinical step

Our experts in pharmacokinetics can perform the services:

  • Participation in the design of the study, including allometric scaling
  • Non-compartmental pharmacokinetics
  • Compartmental pharmacokinetics/simulations
  •  Ascending dose (evaluation of dose proportionality)
  • Repeat dose (evaluation of multiple dose linearity)
  •  Bioavailability and bioequivalence
  •  Drug dose interaction studies
  •  Dedicated populations
  •  Pharmacodynamic modelling and PK/PD
  • Deliverable including pharmacokinetic parameters, complete data analysis and interpretation

Contact us today to talk about your project